Zuffa, LLC, owner of the Ultimate Fighting Championship®, released the following statement today regarding drug test results from UFC on FX 7 that took place in Sao Paulo, Brazil, on January 19, 2013.
All 22 fighters on the UFC on FX 7 card were drug tested at the event and all fighters passed their drug tests with the exception of Thiago Tavares. The results for Tavares showed the presence of Drostanolone, an anabolic steroid and banned substance. Tavares has been informed that he will receive a 9-month suspension retroactive to the date of the event and that he must pass a drug test upon completion of the suspension before receiving clearance to compete again.
To dispel rumors that have been circulated, Zuffa wishes to clarify that Vitor Belfort’s drug test results were negative and did not indicate the presence of any performance enhancing drugs.
Belfort has been on a medically approved testosterone replacement therapy (TRT) regimen under the supervision of a medical doctor from the State of Nevada, after being diagnosed with hypogonadism, or low testosterone. The purpose of a medically administered TRT regimen is to allow patients with hypogonadism to maintain testosterone levels within a range that is normal for an adult male.
Zuffa, LLC, owner of the Ultimate Fighting Championship®, released the following statement today regarding drug test results from UFC on FX 7 that took place in Sao Paulo, Brazil, on January 19, 2013.
All 22 fighters on the UFC on FX 7 card were drug tested at the event and all fighters passed their drug tests with the exception of Thiago Tavares. The results for Tavares showed the presence of Drostanolone, an anabolic steroid and banned substance. Tavares has been informed that he will receive a 9-month suspension retroactive to the date of the event and that he must pass a drug test upon completion of the suspension before receiving clearance to compete again.
To dispel rumors that have been circulated, Zuffa wishes to clarify that Vitor Belfort’s drug test results were negative and did not indicate the presence of any performance enhancing drugs.
Belfort has been on a medically approved testosterone replacement therapy (TRT) regimen under the supervision of a medical doctor from the State of Nevada, after being diagnosed with hypogonadism, or low testosterone. The purpose of a medically administered TRT regimen is to allow patients with hypogonadism to maintain testosterone levels within a range that is normal for an adult male.